Related Experiment Videos
Mitral valve prolapse and the anxiety disorders
S R Dager1, A K Saal, K A Comess
1Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Abstract:
Confusing and contradictory results have emerged from studies of the relationship between anxiety disorders and mitral valve prolapse (MVP), a commonly occurring heart defect that has been associated with chest pain, palpitations, tachycardia, and arrhythmias. Patients with anxiety disorders, particularly panic attacks, appear to have an increased prevalence of MVP compared with control groups or the general population, although most individuals with MVP are asymptomatic. MVP does not appear to distinguish a subgroup of patients with panic disorder on the basis of vulnerability to panic attacks, symptom presentation, biological abnormalities, or treatment response. The authors review some current hypotheses about causal relationships between anxiety disorders and MVP, describe methods of diagnosing MVP and their shortcomings, and identify possible medical complications of MVP and ways to treat or prevent them.
Insights
Anxiety disorders and mitral valve prolapse (MVP) show confusing links. While patients with anxiety may have higher MVP rates, MVP doesn't predict panic disorder characteristics or treatment outcomes.
Area of Science:
- Cardiology
- Psychiatry
- Medical Diagnostics
Background:
- Mitral valve prolapse (MVP) is a common heart defect with varied symptoms.
- Anxiety disorders, especially panic attacks, are frequently observed in patients with MVP.
- Existing research presents conflicting findings on the anxiety disorder-MVP relationship.
Purpose of the Study:
- To clarify the association between anxiety disorders and mitral valve prolapse (MVP).
- To examine if MVP influences panic disorder presentation, vulnerability, or treatment.
- To review diagnostic methods, complications, and management of MVP.
Main Methods:
- Literature review of studies investigating anxiety disorders and MVP.
- Analysis of diagnostic criteria and limitations for MVP.
- Examination of clinical data regarding patient symptoms and treatment responses.
Main Results:
- Studies indicate a higher prevalence of MVP in patients with anxiety disorders compared to general populations.
- MVP does not appear to be a distinguishing factor for panic disorder subgroups.
- Most individuals diagnosed with MVP remain asymptomatic.
Conclusions:
- The relationship between anxiety disorders and MVP requires further investigation due to inconsistent findings.
- MVP diagnosis and its clinical implications need careful consideration.
- Understanding potential complications and preventive strategies for MVP is crucial.